Can serum endoglin be used to improve the diagnostic performance in prostate cancer?
Sign Up to like & getrecommendations! Published in 2021 at "World Journal of Urology"
DOI: 10.1007/s00345-021-03714-5
Abstract: New biomarkers may contribute to avoid unnecessary biopsies resulting from the suboptimal performance of prostate-specific antigen (PSA) testing. This study aimed to assess serum endoglin as a prostate cancer (PCa) diagnostic tool among biopsy candidates.… read more here.
Keywords: cancer; performance prostate; endoglin; serum endoglin ... See more keywords